Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-19

Clinical Trial Update: Determine the Improvement in Activity Status/Quality of Life (QoL) of Patients With Rheumatoid Arthritis (RA) During Treatment With Lodotra (Prednisone)

View source ↗

Summary

This clinical trial update reports results on activity status and quality of life in rheumatoid arthritis patients treated with Lodotra (delayed-release prednis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lodotra (prednisone)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Arthritis, Rheumatoid | Status: COMPLETED